LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET 2019-2027

Lifesciences | Diagnostic & Biotechnology

LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET 2019-2027

Market By Products, Applications, End-users And Geography | Forecast 2019-2027

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Triton Market Research has concluded that the Latin America immunohistochemistry market is projected to grow with a CAGR of 6.85% in the estimated years 2019-2027.

The immunohistochemistry report on the Latin American region includes the countries of:

•            Brazil

•            Mexico

•            Argentina

•            Chile

•            Cuba

•            Rest of Latin America

To get detailed insights on segments, Download Sample Report

Brazil has a noteworthy portion of quality hospitals in Latin America and draws in patients from neighboring countries, mostly for cardiovascular treatment, cancer and plastic surgery. The geriatric population in Brazil is also increasing, which is expected to result in increased healthcare expenditure due to an increase in age-related diseases. Statistics from the National Center for Biotechnology Information (NCBI) suggest cancer to be the second most common cause of death in Brazil after cardiac and cerebrovascular diseases. This trend is expected to result in an increase in demand for tissue diagnostics for the treatment and management of such diseases, thereby positively impacting the immunohistochemistry market in Brazil. The rise in the prevalence of chronic diseases in Cuba has led to an increased demand for IHC reagents, antibodies and diagnostic procedure equipment in hospitals and diagnostic laboratories in Cuba.

The rise in prevalence of chronic diseases in Mexico has led to an increased demand for IHC antibodies, reagents and diagnostic procedures equipment in diagnostic laboratories and hospitals in Mexico. The immunohistochemistry market is expected to observe significant growth in Chile, as a result of a rapidly aging population and increasing prevalence of cancer & other lifestyle diseases such as obesity & other chronic conditions that require tissue diagnostics for detection and treatment. Healthcare expenditure is increasing with the increase in geriatric population and increasing prevalence of diseases. This increase is expected to be from the increased demand for healthcare services owing to the increasing aging populace and the rising prevalence of diseases like cancer. Therefore, increasing healthcare expenditure is expected to have a positive impact on the immunohistochemistry market in Chile.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. HISTORY OF IMMUNOHISTOCHEMISTRY

2.2. VALUE CHAIN OUTLOOK

2.3. KEY INSIGHTS

2.4. MARKET ATTRACTIVENESS MATRIX

2.5. MARKET DRIVERS

2.5.1.   IN-VITRO TECHNOLOGICAL ADVANCEMENTS

2.5.2.   INCREASING CANCER OCCURRENCE

2.5.3.   SWELLING HEALTHCARE SPENDING

2.5.4.   RISING GERIATRIC POPULATION

2.5.5.   INCREASING USE OF POC TESTING

2.6. MARKET RESTRAINTS

2.6.1.   RESTRICTIONS OF CLOSED SYSTEMS

2.6.2.   REIMBURSEMENT ISSUES

2.7. MARKET OPPORTUNITIES

2.7.1.   INCREASING USE OF BIOMARKERS FOR DISEASE DIAGNOSIS

2.7.2.   TECHNOLOGICAL ADVANCEMENTS

2.8. MARKET CHALLENGES

2.8.1.   STRINGENT REGULATIONS

2.8.2.   HIGH MAINTENANCE COST INFLUENCING THE MARKET GROWTH

3.    IMMUNOHISTOCHEMISTRY (IHC) MARKET OUTLOOK - BY PRODUCTS

3.1. ANTIBODIES

3.1.1.   PRIMARY ANTIBODIES

3.1.2.   SECONDARY ANTIBODIES

3.2. EQUIPMENT

3.2.1.   SLIDE STAINING SYSTEMS

3.2.2.   TISSUE MICROARRAYS

3.2.3.   TISSUE PROCESSING SYSTEMS

3.2.4.   SLIDE SCANNERS

3.2.5.   OTHER EQUIPMENT

3.3. REAGENTS

3.3.1.   HISTOLOGICAL STAINS

3.3.2.   BLOCKING SERA AND REAGENTS

3.3.3.   CHROMOGENIC SUBSTRATES

3.3.4.   FIXATION REAGENTS

3.3.5.   STABILIZERS

3.3.6.   ORGANIC SOLVENTS

3.3.7.   PROTEOLYTIC ENZYMES

3.3.8.   DILUENTS

3.4. KITS

4.    IMMUNOHISTOCHEMISTRY (IHC) MARKET OUTLOOK - BY APPLICATIONS

4.1. DIAGNOSTICS

4.1.1.   CANCER

4.1.2.   INFECTIOUS DISEASES

4.1.3.   CARDIOVASCULAR DISEASE

4.1.4.   AUTOIMMUNE DISEASES

4.1.5.   DIABETES MELLITUS

4.1.6.   NEPHROLOGICAL DISEASES

4.2. DRUG TESTING

5.    IMMUNOHISTOCHEMISTRY (IHC) MARKET OUTLOOK - BY END-USERS

5.1. HOSPITALS AND DIAGNOSTIC LABORATORIES

5.2. RESEARCH INSTITUTES

5.3. OTHER END-USERS

6.    IMMUNOHISTOCHEMISTRY (IHC) MARKET - LATIN AMERICA

6.1. COUNTRY ANALYSIS

6.1.1.   BRAZIL

6.1.2.   MEXICO

6.1.3.   ARGENTINA

6.1.4.   CHILE

6.1.5.   CUBA

6.1.6.   REST OF LATIN AMERICA

7.    COMPETITIVE LANDSCAPE

7.1. ABBOTT LABORATORIES

7.2. ABCAM PLC

7.3. AGILENT TECHNOLOGIES, INC.

7.4. BIOGENEX

7.5. BIO-RAD LABORATORIES, INC.

7.6. BIO SB

7.7. CELL SIGNALING TECHNOLOGY, INC.

7.8. DANAHER CORPORATION

7.9. F. HOFFMANN-LA ROCHE AG

7.10.            HISTOLOGIX

7.11.            MERCK MILLIPORE

7.12.            PERKINELMER, INC.

7.13.            SIEMENS AG HEALTHCARE

7.14.            THERMO FISHER SCIENTIFIC, INC.

8.    METHODOLOGY AND SCOPE

8.1. RESEARCH SCOPE

8.2. SOURCES OF DATA

8.3. RESEARCH METHODOLOGY

List of table

TABLE 1       LATIN AMERICA MARKET FOR IMMUNOHISTOCHEMISTRY BY REGION 2019-2027 ($ MILLION)

TABLE 2       CANCER MARKERS USED IN DIAGNOSIS AND TREATMENT

TABLE 3        LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET BY PRODUCTS 2019-2027 ($ MILLION)

TABLE 4        LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN ANTIBODIES BY TYPE 2019-2027 ($ MILLION)

TABLE 5        CLINICALLY IMPORTANT MONOCLONAL ANTIBODIES

TABLE 6        SECONDARY ANTIBODY SELECTIONS

TABLE 7        LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN EQUIPMENT BY TYPES 2019-2027 ($ MILLION)

TABLE 8        LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN REAGENTS BY TYPE 2019-2027 ($ MILLION)

TABLE 9        HISTOLOGY STAINS AND ITS CATEGORIES

TABLE 10      COMMON FIXATIVES AND THEIR GENERAL TARGET ANTIGENS

TABLE 11      LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN KITS 2019-2027 ($ MILLION)

TABLE 12      KIT COMPONENTS ARE AVAILABLE FOR IHC OPTIMIZATION

TABLE 13      LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 14      LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN DIAGNOSTICS BY TYPE 2019-2027 ($ MILLION)

TABLE 15     SELECTED INFECTIOUS ETIOLOGIES OF AUTOIMMUNE DISEASES

TABLE 16      LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET BY END-USERS 2019-2027 ($ MILLION)

TABLE 17     LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET BY COUNTRY 2019-2027 ($ MILLION)

List of Figures

FIGURE 1      LATIN AMERICA MARKET FOR IMMUNOHISTOCHEMISTRY 2019-2027 ($ MILLION)

FIGURE 2      HISTORY OF IMMUNOHISTOCHEMISTRY

FIGURE 3      LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN ANTIBODIES 2019-2027 ($ MILLION)

FIGURE 4      LATIN AMERICA ANTIBODIES MARKET IN PRIMARY ANTIBODIES 2019-2027 ($ MILLION)

FIGURE 5      LATIN AMERICA ANTIBODIES MARKET IN SECONDARY ANTIBODIES 2019-2027 ($ MILLION)

FIGURE 6      LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN EQUIPMENT 2019-2027 ($ MILLION)

FIGURE 7      LATIN AMERICA EQUIPMENT MARKET IN SLIDE STAINING SYSTEMS 2019-2027 ($ MILLION)

FIGURE 8      LATIN AMERICA EQUIPMENT MARKET IN TISSUE MICROARRAYS 2019-2027 ($ MILLION)

FIGURE 9      LATIN AMERICA EQUIPMENT MARKET IN TISSUE PROCESSING SYSTEMS 2019-2027 ($ MILLION)

FIGURE 10   LATIN AMERICA EQUIPMENT MARKET IN SLIDE SCANNERS 2019-2027 ($ MILLION)

FIGURE 11   LATIN AMERICA EQUIPMENT MARKET IN OTHER EQUIPMENT 2019-2027 ($ MILLION)

FIGURE 12   LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN REAGENTS 2019-2027 ($ MILLION)

FIGURE 13   LATIN AMERICA REAGENTS MARKET IN HISTOLOGICAL STAINS 2019-2027 ($ MILLION)

FIGURE 14   LATIN AMERICA REAGENTS MARKET IN BLOCKING SERA AND REAGENTS 2019-2027 ($ MILLION)

FIGURE 15   LATIN AMERICA REAGENTS MARKET IN CHROMOGENIC SUBSTRATES 2019-2027 ($ MILLION)

FIGURE 16   LATIN AMERICA REAGENTS MARKET IN FIXATION REAGENTS 2019-2027 ($ MILLION)

FIGURE 17   LATIN AMERICA REAGENTS MARKET IN STABILIZERS 2019-2027 ($ MILLION)

FIGURE 18   LATIN AMERICA REAGENTS MARKET IN ORGANIC SOLVENTS 2019-2027 ($ MILLION)

FIGURE 19   LATIN AMERICA REAGENTS MARKET IN PROTEOLYTIC ENZYMES 2019-2027 ($ MILLION)

FIGURE 20   LATIN AMERICA REAGENTS MARKET IN DILUENTS 2019-2027 ($ MILLION)

FIGURE 21   PHASES OF HISTOLOGICAL STAINING

FIGURE 22   LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN KITS 2019-2027 ($ MILLION)

FIGURE 23   LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN DIAGNOSTICS 2019-2027 ($ MILLION)

FIGURE 24   LATIN AMERICA DIAGNOSTICS MARKET IN CANCER 2019-2027 ($ MILLION)

FIGURE 25   LATIN AMERICA DIAGNOSTICS MARKET IN INFECTIOUS DISEASES 2019-2027 ($ MILLION)

FIGURE 26   LATIN AMERICA DIAGNOSTICS MARKET IN CARDIOVASCULAR DISEASE 2019-2027 ($ MILLION)

FIGURE 27   LATIN AMERICA DIAGNOSTICS MARKET IN AUTOIMMUNE DISEASES 2019-2027 ($ MILLION)

FIGURE 28   LATIN AMERICA DIAGNOSTICS MARKET IN DIABETES MELLITUS 2019-2027 ($ MILLION)

FIGURE 29   LATIN AMERICA DIAGNOSTICS MARKET IN NEPHROLOGICAL DISEASES 2019-2027 ($ MILLION)

FIGURE 30   LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN DRUG TESTING 2019-2027 ($ MILLION)

FIGURE 31   LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN HOSPITALS AND DIAGNOSTIC LABORATORIES 2019-2027 ($ MILLION)

FIGURE 32   LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN RESEARCH INSTITUTES 2019-2027 ($ MILLION)

FIGURE 33   LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN OTHER END-USERS 2019-2027 ($ MILLION)

FIGURE 34   LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 35   BRAZIL IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 36   HEALTHCARE SPENDING IN MEXICO 2014 AND 2040 ($ BILLION)

FIGURE 37   MEXICO IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 38   HEALTHCARE SPENDING IN ARGENTINA 2014 AND 2040 ($ BILLION)

FIGURE 39   ARGENTINA IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 40   CHILE IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 41   HEALTHCARE EXPENDITURE IN CHILE 2005-2016 (PERCENTAGE SHARE OF GDP)

FIGURE 42   HEALTHCARE SPENDING IN CUBA (2014 AND 2040)

FIGURE 43   CUBA IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 44   REST OF LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;